ISO 25539-3:2011
Cardiovascular implants — Endovascular devices — Part 3: Vena cava filters
Cardiovascular implants — Endovascular devices — Part 3: Vena cava filters
- Статус документа:
- Отменён
- Формат:
- Электронный (PDF)
- Количество страниц:
- 93
- Дата публикации:
- 25 ноября 2011 г.
- Издание:
- ISO IS 25539 edition 1 version 1
- ICS:
- 11.040.40
ISO 25539-3:2011 specifies requirements for vena cava filters, based upon current medical knowledge. With regard to safety, it gives requirements for intended performance, design attributes, materials, design evaluation, manufacturing, sterilization, packaging and information supplied by the manufacturer. ISO 25539-3:2011 supplements ISO 14630, which specifies general requirements for the performance of non-active surgical implants. The following are within the scope of ISO 25539-3:2011: vena cava filters used to prevent pulmonary embolism by mechanical filtration in the inferior vena cava: while ISO 25539-3:2011 might be useful with respect to filters implanted in other venous locations (e.g. superior vena cava, iliac veins), it does not specifically address use of filters in other implantation sites; sheath/dilator kits, providing that they comprise an integral component of the access, delivery or retrieval/conversion of the vena cava filter. delivery systems, providing that they comprise an integral component of the deployment of the vena cava filter. optional filters that can be retrieved or converted, and permanent filters together with their associated endovascular systems: while ISO 25539-3:2011 might be useful with respect to the evaluation of repositioning filters after chronic implantation, it does not specifically address filter repositioning. The following are outside the scope of ISO 25539-3:2011: temporary filters (e.g. tethered) that need to be removed after a defined period of time; coatings, surface modifications, and/or drugs; issues associated with viable tissues and non-viable biological materials; degradation and other time-dependent aspects of absorbable materials; procedures and devices (e.g. venous entry needle) used prior to the vena cava filter procedure.
Abstract
Overview
ISO 25539-3:2011 - Cardiovascular implants - Endovascular devices - Part 3: Vena cava filters - specifies safety and performance requirements for vena cava filters used to prevent pulmonary embolism by mechanical filtration in the inferior vena cava (IVC). The standard complements ISO 14630 (non‑active surgical implants) and sets requirements for intended performance, design attributes, materials, design evaluation, manufacturing, sterilization, packaging and the information supplied by the manufacturer. It covers filter systems, delivery systems, sheath/dilator kits, and optional retrievable or convertible filters intended as permanent implants.
Key technical topics and requirements
- Scope and classification
- Defines device classification by access site, orientation, implantation site, type (permanent/optional), materials and size.
- Intended performance and design attributes
- Specifies functional expectations for filters, delivery systems and sheath/dilator kits to ensure safe deployment, access and retrieval/conversion when applicable.
- Materials and biocompatibility
- Requires consideration of materials of construction in line with biological evaluation referenced standards.
- Design evaluation
- Requires documented bench and analytical testing, preclinical in vivo evaluation and clinical evaluation to address potential failure modes and detrimental clinical effects.
- Risk management and reporting
- Emphasizes identification of failure modes, potential device effects and clinical consequences; test selection and rationale must be recorded.
- Manufacturing, sterilization and packaging
- Sets expectations for controlled manufacturing processes, validated sterilization (products supplied sterile or non‑sterile) and packaging that protects sterile barrier systems.
- Information supplied
- Requires clear labelling and instructions for use (IFU) covering access site, deployment, retrieval/conversion procedures and limitations.
- Post‑market surveillance
- Calls for ongoing monitoring to detect device performance issues and adverse events in clinical practice.
Practical applications - who uses ISO 25539-3
- Medical device manufacturers designing or marketing IVC filters (permanent, retrievable/convertible) use the standard to define product requirements and test programs.
- Design engineers and R&D teams for developing delivery systems, sheath/dilator kits and endovascular systems.
- Regulatory affairs and quality assurance for compiling technical files, conformity assessment and compliance with international expectations.
- Test laboratories and preclinical/clinical researchers conducting bench tests, animal studies and clinical evaluations.
- Notified bodies and health authorities assessing device safety, labeling and post‑market data.
Related standards (normative references)
- ISO 14630 (Non‑active surgical implants)
- ISO 10993 series (Biological evaluation)
- ISO 14971 (Risk management)
- ISO 11135, ISO 11137, ISO 17665‑1, ISO 14937 (Sterilization)
- ISO 11607‑1 (Packaging for terminally sterilized medical devices)
Keywords: ISO 25539-3, vena cava filters, endovascular devices, cardiovascular implants, IVC filter design, filter retrieval, sterilization, medical device standards.
Технические детали
- Технический комитет
- ISO/TC 150/SC 2 - Cardiovascular implants and extracorporeal systems
- SKU
- ISO 25539-3:2011
Похожие стандарты
Стандарты, упомянутые в описании
BS EN ISO 14630:2024
ДействующийNon-active surgical implants. General requirements.
ISO 10993-12:2012
ОтменёнBiological evaluation of medical devices — Part 12: Sample preparation and reference materials
ISO 14971:2007
ДействующийMedical devices - Application of risk management to medical devices
Overview ISO 14971:2007 - Medical devices - Application of risk management to medical devices - defines a systematic process for identifying hazards, estimating and evaluating risks, implementing ris…
ISO 11135:2014
ДействующийSterilization of health-care products — Ethylene oxide — Requirements for the development, validation and rou…
Overview ISO 11135:2014 - Sterilization of health‑care products - Ethylene oxide specifies the requirements for the development, validation and routine control of an ethylene oxide (EO) sterilization…
ISO 11137-2:2013
ДействующийSterilization of health care products — Radiation — Part 2: Establishing the sterilization dose
Overview ISO 11137-2:2013 - “Sterilization of health care products - Radiation - Part 2: Establishing the sterilization dose” specifies validated methods to determine the minimum radiation dose requi…